Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Therapy in Rectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02551237
What this trial is testing

Neoadjuvant Treatment for Advanced Rectal Carcinoma

Who this might be right for
Rectal Carcinoma
UNICANCER 103
Large-scale testing (Phase 3)UnknownNCT05079438
What this trial is testing

Dendrobium Huoshanense Suppository in Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Zhejiang Cancer Hospital 168
Testing effectiveness (Phase 2)Looking for participantsNCT05672524
What this trial is testing

Tucatinib and Trastuzumab in People With Rectal Cancer

Who this might be right for
Adenocarcinoma of the RectumLocally Advanced Rectal AdenocarcinomaRectal Adenocarcinoma+2 more
Memorial Sloan Kettering Cancer Center 37
Testing effectiveness (Phase 2)Looking for participantsNCT06850103
What this trial is testing

SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases

Who this might be right for
Colorectal CarcinomaOligometastasespMMR+2 more
First Affiliated Hospital of Zhejiang University 51
Large-scale testing (Phase 3)Study completedNCT00979680
What this trial is testing

Sphincter-preserving Surgery After Preoperative Treatment of Ultra-low Rectal Carcinoma

Who this might be right for
Rectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 207
Testing effectiveness (Phase 2)Active Not RecruitingNCT05507112
What this trial is testing

TIME in Immunotherapy Combined With nCRT for Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Peking Union Medical College Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04751370
What this trial is testing

Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal AdenocarcinomaStage II Rectal Cancer AJCC v8Stage III Rectal Cancer AJCC v8
National Cancer Institute (NCI) 31
Large-scale testing (Phase 3)Not Yet RecruitingNCT07118800
What this trial is testing

Study Evaluating Two Treatment Strategies for Rectal Cancer in Patients ≥75 Years Old

Who this might be right for
Locally Advanced Rectal Adenocarcinoma
UNICANCER 160
Testing effectiveness (Phase 2)Study completedNCT03443661
What this trial is testing

Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Aiping Zhou 50
Testing effectiveness (Phase 2)Study completedNCT00700570
What this trial is testing

Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 45
Testing effectiveness (Phase 2)Study completedNCT01397305
What this trial is testing

An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer

Who this might be right for
Rectal Cancer
Isofol Medical AB 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07248020
What this trial is testing

A Phase II Single-Arm Study of High-Bioavailability Curcumin as Neoadjuvant Chemoradiotherapy in Mid-to-Low Rectal Cancer: Integrated Clinical and Translational Analysis of Tumor Tissue

Who this might be right for
Rectal CancerLocally Advanced Rectal CancerRadiation-Induced Enteritis+2 more
Chang Gung Memorial Hospital 72
Not applicableStudy completedNCT00628368
What this trial is testing

Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer

Who this might be right for
Colorectal CancerEsophageal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT02008656
What this trial is testing

Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management

Who this might be right for
Rectal Cancer
Memorial Sloan Kettering Cancer Center 358
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07765667
What this trial is testing

NCT + PD1 + Ketogenic Diet and/or Vitamin C for LARC

Who this might be right for
Rectal AdenocarcinomaHigh-Risk CancerMSS
Sixth Affiliated Hospital, Sun Yat-sen University 100
Not applicableLooking for participantsNCT05883800
What this trial is testing

Total Neoadjuvant Treatment Combined With Adaptive Radiotherapy for Rectal Cancer

Who this might be right for
Rectal Cancer
Haukeland University Hospital 61
Testing effectiveness (Phase 2)WithdrawnNCT00408772
What this trial is testing

Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
University of California, Davis
Testing effectiveness (Phase 2)Looking for participantsNCT05571644
What this trial is testing

Neoadjuvant Treatment With mFOLFOXIRI Plus Cadonilimab (AK104) Versus mFOLFOX6 in Locally Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sun Yat-sen University 143
Testing effectiveness (Phase 2)UnknownNCT05980689
What this trial is testing

Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Sun Yat-sen University 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243938
What this trial is testing

Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)

Who this might be right for
Locally Advanced Rectal Cancer (LARC)Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal Cancer (mCRC)+1 more
Tao Zhang 70
Next Page